Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes
Quinoxalines are benzopyrazine derivatives with significant therapeutic impact in the pharmaceutical industry. They proved to be useful against inflammation, bacterial, fungal, viral infection, diabetes and other applications. Very recently, in January 2024, the FDA approved new quinoxaline containi...
| Published in: | Journal of Enzyme Inhibition and Medicinal Chemistry |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Taylor and Francis Ltd.
2024
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204755142&doi=10.1080%2f14756366.2024.2395985&partnerID=40&md5=fe821bf9fa1fe8b3edbe39a5d37af6ce |